TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cogstate Ltd ( (AU:CGS) ) has issued an announcement.
Cogstate Ltd has announced the final notification of its on-market buy-back program, with a total of 5,870,804 ordinary fully paid securities repurchased for a consideration of AUD 7,646,946.04. This buy-back is part of the company’s strategy to optimize its capital structure, potentially enhancing shareholder value and reflecting confidence in its financial position.
The most recent analyst rating on (AU:CGS) stock is a Buy with a A$3.00 price target. To see the full list of analyst forecasts on Cogstate Ltd stock, see the AU:CGS Stock Forecast page.
More about Cogstate Ltd
Cogstate Ltd operates in the healthcare industry, primarily focusing on cognitive science and technology. The company provides digital cognitive assessment tools and services, catering to clinical trials, academic research, and healthcare markets.
YTD Price Performance: 161.37%
Average Trading Volume: 252,584
Technical Sentiment Signal: Buy
Current Market Cap: A$463.4M
Learn more about CGS stock on TipRanks’ Stock Analysis page.